ReviewInternational journal of molecular sciences2020

Exploration of Feasible Immune Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma Treatment in Real World Clinical Practice.

Hui-Ching Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.